2011 Agenda

MONDAY, JULY 11

5:00 – 8:00 PM

Registration

TUESDAY, JULY 12

7:30 AM	Registration Opens
7:45 – 8:45 AM	Continental Breakfast in Exhibit/Poster Area
8:45 – 9:00 AM	Welcome to DNA Vaccines 2011 David Weiner, PhD – Professor, University of Pennsylvania
9:00 – 9:30 AM	The Future of Vaccines: Opportunities and Challenges John Shiver, PhD – Vice President, Vaccines Discovery, Merck Research Laboratories
9:30 – 10:00 AM	Antibody and B Cell Responses to the HIV-1 Envelope Glycoproteins Rich Wyatt, PhD – Director of Viral Immunology, IAVI Center for Neutralizing Antibodies at TSRI, Professor of Immunolgy, The Scripps Research Institute
10:00 – 10:30 AM	RV-144 & What’s Next in Protective HIV Vaccine Trials Merlin Robb, MD – HJF HIV Program Director, U.S. Military HIV Research Program
10:30 – 11:00 AM	Coffee/Networking Break in Exhibit/Poster Area

Approaches to HIV Session

11:00 – 11:20 AM	Prime-boost Strategies for Protective Immunity Against HIV Susan Barnett, PhD – Senior Project Leader, Senior Director, Vaccine Research, Novartis Vaccines & Diagnostics
11:22 – 11:44 AM	GeoVax DNA/MVA HIV Vaccine, Preclinical and Clinical Studies Harriet Robinson, PhD – Chief Scientific Officer, GeoVax, Inc.
11:44 AM – 12:06 PM	Novel Prime Boost Approaches to Drive Protective Immunity against HIV Shan Lu, MD, PhD – Professor of Medicine, University of Massachusetts Medical School
12:06 – 12:30 PM	Preclinical and Clinical Approaches to Genetic HIV Vaccines Britta Wahren, MD, PhD – Professor, Karolinska Institutet
12:30 – 1:45 PM	Lunch in Exhibit/Poster Area

DNA & EP Session

1:45 – 2:10 PM	DNA and Protein Vaccination Confers Protection Upon Mucosal Challenge with Heterologous SIVsmE660 in Rhesus Macaques Barbara Felber, PhD – Principal Investigator, National Cancer Institute
2:10 – 2:35 PM	Expanded Clinical Testing of an Integrated Device Technology for Electroporation Mediated DNA Vaccine Delivery Drew Hannaman – Vice President, Ichor Medical Systems, Inc
2:35 – 3:05 PM	Engineering DNA Approaches for HIV David Weiner, PhD – Professor, University of Pennsylvania
3:05 – 3:30 PM	Coffee/Networking Break in Exhibit/Poster Area

Approaches to Infectious Disease Session

3:30 – 4:00 PM	Phase 2 Clinical Trial Results of a Therapeutic DNA Vaccine, TransVax™, for Control of Cytomegalovirus in Hematopoietic Cell Transplant Recipients Alain Rolland, PhD – Executive Vice President, Product Development, Vical Inc
4:00 – 4:30 PM	Prime Boost Malaria Vaccines Thomas Richie, MD, PhD – Research Coordinator, US Military Malaria Vaccine Program, Naval Medical Research Center
4:30 – 5:30PM	Plenary Roundtable I – Chairs John Sterling & David Weiner Development and Commercialization of Novel Vaccines Kathrin Jansen, PhD – Senior Vice President, Vaccine Research & Early Development, Pfizer, Inc. Niranjan Sardesai, PhD – Senior Vice President, Inovio Pharmaceuticals, Inc. Alain Rolland, PhD – Executive Vice President, Product Development, Vical, Inc. Jeffrey Ulmer, PhD – Global Head, External Research, Novartis Vaccines & Diagnostics
5:30 – 7:00 PM	Cocktail Reception in Exhibit/Poster Area

WEDNESDAY, JULY 13

7:30 AM

Registration Opens

Immune Mechanisms & Vaccine Session

7:45 – 8:45 AM	Continental Breakfast in Exhibit/Poster Area
8:45 – 915 AM	Correlates of Immunity After Vaccination Stanley Plotkin, PhD – Emeritus Professor, Wistar Institute and University of Pennsylvania, Professor, Johns Hopkins Bloomberg School of Public Health, Consultant, Sanofi Pasteur & Principal of Vaxconsult
9:15 – 9:40 AM	Follicular Helper CD4 T Cell Differentiation and the Development of Protective Antibody Responses Shane Crotty, PhD – Associate Professor, Vaccine Discovery, La Jolla Institute for Allergy & Immunology
9:40 – 10:05 AM	Novel Approaches to T Cell Analysis in Vaccination Mike Betts, PhD – Assistant Professor, Microbiology, University of Pennsylvania
10:05 – 10:30 AM	Non Human Primates in the Evaluation of Vectored Vaccine Approaches Danilo Casimiro, PhD – Director, Vaccine R&D, Merck & Co
10:30 – 11:00 AM	Coffee/Networking Break in Exhibit/Poster Area

Infectious Diseases Session

11:00 – 11:20 AM	Vaccines for Agents of Bioterrorism Connie Schmaljohn, PhD – Chief Scientist, Infectious Diseases, US Army Medical Research Institute of Infectious Diseases
11:25 – 11:45 AM	DNA Vaccines for Tuberculosis Thomas Evans, MD – Chief Scientific Officer, Aeras
11:50 – 12:10 PM	Approaches to HCV Virus Infection Matti Sällberg, PhD – Professor, Karolinska Institutet
12:10 – 12:30 PM	Vaccines for Pandemics Gary Kobinger, PhD – Chief, Special Pathogens, Public Health Agency of Canada
12:30 – 4:00 PM	Break to Explore downtown Coronado Bay and/or San Diego Complimentary transportation to downtown Coronado and discounted cabs to San Diego

New Vaccine Approaches Session

4:00 – 4:20 PM	New Applications of DNA Vaccines Bin Wang, PhD – Professor, Fudan University Shanghai Medical College
4:20 – 4:40 PM	Improved Anti-Viral Immunity Provided by pDNA Prime/rVSV Boost Immunization Mike Egan, PhD – Director of Immunology, Profectus Biosciences
4:40 – 5:00 PM	Targeting T Cells Through Vaccination Michele Kutzler, PhD – Assistant Professor, Drexel University College of Medicine
5:00 – 5:50 PM	Plenary Roundtable II – Chair Jeffrey Ulmer Vaccines for Emerging Markets Thomas Evans, MD – Chief Scientific Officer, Aeras Ashley J. Birkett, PhD – Director, Pre- and Early-Clinical Research and Development, PATH Malaria Vaccine Initiative (MVI) Thomas Richie, MD, PhD – Research Coordinator, US Military Malaria Vaccine Program, Naval Medical Research Center Stanley Plotkin, PhD – Emeritus Professor, Wistar Institute and University of Pennsylvania, Professor, Johns Hopkins Bloomberg School of Public Health, Consultant, Sanofi Pasteur & Principal of Vaxconsult Merlin Robb, MD – Deputy Director, Clinical Research, US Military HIV Research Program Danilo Casimiro, PhD – Director, Vaccine R&D, Merck & Co

6:00 – 7:30 PM

Cocktail Reception in Exhibit/Poster Area

7:30 – 10:00 PM

Gala Dinner Sponsored by Inovio & VGXi Dinner Presentation by Kathrin Jansen, PhD – Senior Vice President, Vaccine Research & Early Development, Pfizer, Inc.

THURSDAY, JULY 14

7:30 AM	Registration Opens
7:30 – 8:30 AM	Continental Breakfast in Exhibit/Poster Area

Industry Session

8:30 – 8:45 AM	Scale-up of a Plasmid DNA Purification Process Based on PlasmidSelect Xtra for Production of GMP Grade pDNA Tony Hitchcock – Head of Manufacturing Technologies, RecipharmCobra Biologics
8:45 – 9:00 AM	Scaleable and Continuous GMP Plasmid Purification Process Philippe Ledent, PhD – Process Transfer & Development Manager, Eurogentec Biologics
9:00 – 9:15 AM	TBD
9:15 – 9:30 AM	TBD

Abstract Session 1

9:30 – 9:45 AM	TBD
9:45 – 10:00 AM	TBD
10:00 – 10:15 AM	Antitumor Therapeutic Efficacy of cDNA Delivered by Electroporation in Animal Tumor Models Jeong-Im Sin, PhD – Professor of Microbiology, Kangwon National University School of Medicine
10:15 – 10:30 AM	Importance of Electrode Choice on Gene Electrotransfer to Skin Julie Gehl, MD – Clinical Associate Research Professor, Copenhagen University Hospital Herlev
10:30 – 11:00 AM	Coffee/Networking Break in Exhibit/Poster Area

Cancer Session

11:00 – 11:30 AM	Targeting Tumors with T cells: The Normal Repertoire and Beyond Phil Greenberg, MD – Professor, Immunology and Medicine/Oncology, University of Washington and Fred Hutchinson Cancer Research Center
11:30 AM – 12:00 PM	Therapeutic HPV Vaccines Cornelia Trimble, MD – Associate Professor, Gynecology & Obstetrics, Johns Hopkins University School of Medicine
12:00 – 12:30 PM	Clinical Studies of DNA Vaccination Mark Bagarazzi, MD – Chief Medical Officer, Inovio Pharmaceuticals
12:30 – 1:30 PM	Lunch in Exhibit/Poster Area

Tumor Immune Therapy Session

1:30 – 2:00 PM	Cancer Immune Therapy Christian Ottensmeier, MD, PhD – Professor of Experimental Medicine, University of Southampton, Cancer Sciences
2:00 – 2:30 PM	Immunotherapy for Cancer Facilitated by Electro Gene Transfer Richard Heller, PhD – Director and Professor, Frank Reidy Research Center for Bioelectrics
2:30 – 3:00pm	Electroporative Gene Therapy with IL-12 Plasmid in Metastatic Melanoma Adil Daud, MD – Clinical Professor of Medicine, University of California, San Francisco
3:00 – 3:30 PM	Coffee/Networking Break in Exhibit/Poster Area

Abstract Session 2

3:30 – 3:45 PM	TBD
3:45 – 4:00 PM	TBD
4:00 – 4:15 PM	TBD
4:15 – 4:30 PM	TBD

4:30 PM

Closing Summary

5:00 PM

Meeting Adjourns